| Bioactivity | PKCα (C2-4) inhibitor peptide is a PKCα‐specific inhibitor peptide that blocks the inhibition of IKr by the α1A‐adrenoreceptor agonist A-61603 (HY-101366)[1]. |
| Target | PKCα |
| Name | PKCα (C2-4) inhibitor peptide |
| Sequence | Ser-Leu-Asn-Pro-Glu-Tyr-Arg-Gln-Thr |
| Shortening | SLNPEYRQT |
| Formula | C47H74N14O17 |
| Molar Mass | 1107.17 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu X, et al. Different protein kinase C isoenzymes mediate inhibition of cardiac rapidly activating delayed rectifier K+ current by different G-protein coupled receptors. Br J Pharmacol. 2017 Dec;174(23):4464-4477. |
PKCα (C2-4) inhibitor peptide
CAS: F: C47H74N14O17 W: 1107.17
PKCα (C2-4) inhibitor peptide is a PKCα‐specific inhibitor peptide that blocks the inhibition of IKr by the α1A‐adr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.